First-line Palbociclib and Endocrine Therapy for Patients With HR+/HER2- Advanced Breast Cancer in the Real-world Setting.
Clinical trial NCT04767594 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04767594
- Sponsor
- Pfizer
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2020-10-27
- Primary completion
- 2028-04-03
- Enrollment
- 1407
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.